SCHEDULE: Perceptive Advisors Discloses 6.55% Stake in Celcuity
Beneficial Ownership Disclosure
Perceptive Advisors and related entities have disclosed a 6.55% passive ownership stake in Celcuity Inc., holding 2,670,597 shares.
Summary
- Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. collectively reported beneficial ownership of 2,670,597 shares of Celcuity Inc. common stock.
- This represents 6.55% of Celcuity Inc.'s outstanding common stock.
- The reporting persons hold shared voting and shared dispositive power over all beneficially owned shares.
- The shares were acquired for investment purposes and not with the intent to change or influence control of Celcuity Inc.
Sentiment
Score: 6
Explanation: The disclosure of a significant passive stake by a reputable investment firm like Perceptive Advisors is generally viewed as a positive signal of institutional confidence in the issuer, although it does not imply active engagement in corporate governance.
Positives
- Perceptive Advisors, a prominent investment manager, has taken a significant 6.55% stake in Celcuity Inc., potentially signaling confidence in the company's prospects.
Management Comments
- To the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Industry Context
The disclosure of a significant passive stake by an institutional investor like Perceptive Advisors, which specializes in life sciences, is a common occurrence in the biotechnology and pharmaceutical sectors. Such investments often reflect a long-term view on the potential of companies within this innovation-driven industry.
Stakeholder Impact
- Shareholders: Increased institutional ownership may provide a sense of validation and potentially attract further investor interest, contributing to market liquidity.
Key Dates
| Date | Description |
|---|---|
| June 30, 2025 | Date as of which 38,914,208 shares of Common Stock were outstanding, used for percentage calculation. |
| July 30, 2025 | Date of the event which required the filing of this statement. |
| July 31, 2025 | Date Celcuity Inc.'s Prospectus was filed, reporting 1,836,842 shares issued in an offering. |
| August 4, 2025 | Date the Schedule 13G was signed by the reporting persons. |
Recommendation
holdThe filing indicates a significant passive stake by a reputable institutional investor, which can be a positive signal. However, as a Schedule 13G, it explicitly states no intent to influence control, limiting its direct impact on strategic direction. Further analysis of Celcuity Inc.'s fundamentals and market conditions is required for a more definitive investment recommendation.
Keywords
Celcuity Inc., Perceptive Advisors, Joseph Edelman, Perceptive Life Sciences Master Fund, Common Stock, Beneficial Ownership, Schedule 13G, Investment, Shareholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.